pricing strategies

Valeant Pharma investing in R&D; All eyes on Q4 results

Drug maker Valeant Pharmaceuticals International Inc is facing a variety of problems. Valeant has changed its aggressive investment strategy and turned keen on research and development. Valeant is also facing Federal investigation over its pricing strategies.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics